{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:58:53Z","timestamp":1790711933952,"version":"4.1.0"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,6]]},"DOI":"10.18632\/oncotarget.20944","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T23:19:01Z","timestamp":1505517541000},"page":"81001-81013","source":"Crossref","is-referenced-by-count":166,"title":["PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice"],"prefix":"10.18632","volume":"8","author":[{"given":"Na","family":"Huang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China"},{"name":"Key Laboratory of Ministry of Education for Protection and Utilization of Special Biological Resources in Western China, Ningxia University, Yinchuan 750021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ge","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Protection and Utilization of Special Biological Resources in Western China, Ningxia University, Yinchuan 750021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Tian","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,15]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Lee","year":"2004","journal-title":"Nat Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","article-title":"Alzheimer's disease mechanisms and emerging roads to novel therapeutics","volume":"39","author":"De Strooper","year":"2016","journal-title":"Annu Rev Neurosci"},{"key":"3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Hardy","year":"2016","journal-title":"EMBO Mol Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"Selkoe","year":"2007","journal-title":"J Neurochem"},{"key":"5","doi-asserted-by":"publisher","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases","volume":"3","author":"Masliah","year":"2008","journal-title":"PLoS One"},{"key":"6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-014-0089-7","article-title":"BACE1 inhibitor drugs in clinical trials for Alzheimer's disease","volume":"6","author":"Vassar","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fnagi.2014.00165","article-title":"beta-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease","volume":"6","author":"Claassen","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"8","doi-asserted-by":"publisher","first-page":"13554","DOI":"10.1073\/pnas.241509198","article-title":"Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase","volume":"98","author":"Hashimoto","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9","doi-asserted-by":"publisher","first-page":"14865","DOI":"10.1074\/jbc.M206262200","article-title":"Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta -secretase (BACE1)","volume":"278","author":"Hashimoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10","doi-asserted-by":"publisher","first-page":"48713","DOI":"10.1074\/jbc.M303861200","article-title":"The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1","volume":"278","author":"Seed","year":"2003","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"publisher","first-page":"23009","DOI":"10.1074\/jbc.M414648200","article-title":"beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase","volume":"280","author":"Nukina","year":"2005","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1523\/JNEUROSCI.5207-14.2015","article-title":"Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves","volume":"35","author":"Yan","year":"2015","journal-title":"J Neurosci"},{"key":"13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1326-6-88","article-title":"The Alzheimer's beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb","volume":"6","author":"Vassar","year":"2011","journal-title":"Mol Neurodegener"},{"key":"14","doi-asserted-by":"publisher","first-page":"e48540","DOI":"10.1371\/journal.pone.0048540","article-title":"A peptide binding to the beta-site of APP improves spatial memory and attenuates Abeta burden in Alzheimer's disease transgenic mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice","volume":"93","author":"Cardona-Gomez","year":"2015","journal-title":"Neuropharmacology"},{"key":"16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease--a double-edged sword","volume":"35","author":"Mucke","year":"2002","journal-title":"Neuron"},{"key":"17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.neuro.2012.03.003","article-title":"Rutin inhibits beta-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines","volume":"33","author":"Liu","year":"2012","journal-title":"Neurotoxicology"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.2174\/1567201814666170320142851","article-title":"Anti inflammatory and anti arthritic activity of different milk based formulation of curcumin in rat model","author":"Gupta","year":"2017","journal-title":"Curr Drug Deliv"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25778","article-title":"Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades?","author":"Sahebkar","year":"2017","journal-title":"J Cell Physiol"},{"key":"20","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1017\/S1462399411002055","article-title":"Challenges associated with curcumin therapy in Alzheimer disease","volume":"13","author":"Ramassamy","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"e1002256","DOI":"10.1371\/journal.pmed.1002256","article-title":"Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery","volume":"14","author":"Bennett","year":"2017","journal-title":"PLoS Med"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy","author":"Chaves","year":"2016","journal-title":"Future Med Chem"},{"key":"23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Bernardino","year":"2016","journal-title":"J Control Release"},{"key":"24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","article-title":"PLGA: a unique polymer for drug delivery","volume":"6","author":"Dhawan","year":"2015","journal-title":"Ther Deliv"},{"key":"25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","article-title":"Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease","volume":"148","author":"Wang","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2174\/1567205012666151027121622","article-title":"Enhanced hippocampal neurogenesis in APP\/Ps1 mouse model of Alzheimer's disease after implantation of VEGF-loaded PLGA Nanospheres","volume":"12","author":"Hernandez","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt\/beta-catenin pathway","volume":"8","author":"Gupta","year":"2014","journal-title":"ACS Nano"},{"key":"28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Furnari","year":"2011","journal-title":"J Clin Invest"},{"key":"30","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1021\/acs.molpharmaceut.5b00222","article-title":"Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin\/transferrin receptor complex","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Pharm"},{"key":"31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/IJN.S52236","article-title":"Nanoscale drug delivery systems and the blood-brain barrier","volume":"9","author":"Kuznetsov","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges","volume":"245","author":"Hanafy","year":"2017","journal-title":"J Control Release"},{"key":"33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","article-title":"Double emulsion solvent evaporation techniques used for drug encapsulation","volume":"496","author":"Elaissari","year":"2015","journal-title":"Int J Pharm"},{"key":"34","first-page":"749","article-title":"Systemic delivery to central nervous system by engineered PLGA nanoparticles","volume":"8","author":"Chen","year":"2016","journal-title":"Am J Transl Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","article-title":"TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs","volume":"29","author":"Labhasetwar","year":"2008","journal-title":"Biomaterials"},{"key":"36","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s11095-013-1249-3","article-title":"Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies","volume":"31","author":"Antimisiaris","year":"2014","journal-title":"Pharm Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.nano.2016.12.003","article-title":"New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe\/PS1dE9","volume":"13","author":"Garcia","year":"2016","journal-title":"Nanomedicine"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-016-0637-z","article-title":"Neuroinflammation, immune system and Alzheimer disease: searching for the missing link","author":"Ricevuti","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","article-title":"Targeting microglia for the treatment of Alzheimer's Disease","volume":"64","author":"Gan","year":"2016","journal-title":"Glia"},{"key":"40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1381612822666151125000300","article-title":"Inflammatory process in Alzheimer's and Parkinson's diseases: central role of cytokines","volume":"22","author":"Haque","year":"2016","journal-title":"Curr Pharm Des"},{"key":"41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejps.2011.02.009","article-title":"Curcumin activates Wnt\/beta-catenin signaling pathway through inhibiting the activity of GSK-3beta in APPswe transfected SY5Y cells","volume":"42","author":"Li","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s12035-016-9802-9","article-title":"Curcumin ameliorates memory decline via inhibiting BACE1 expression and beta-amyloid pathology in 5xFAD transgenic mice","volume":"54","author":"Chen","year":"2017","journal-title":"Mol Neurobiol"},{"key":"43","doi-asserted-by":"publisher","first-page":"e32616","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease","volume":"7","author":"Kumar","year":"2012","journal-title":"PLoS One"},{"key":"44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/02652048.2015.1134689","article-title":"Co-encapsulation of Nigella sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer's disease","volume":"33","author":"Mohamed","year":"2016","journal-title":"J Microencapsul"},{"key":"45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","article-title":"Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice","volume":"80","author":"Jiang","year":"2016","journal-title":"Biomaterials"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:14:20Z","timestamp":1589202860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,15]]},"references-count":45,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2017,10,6]]}},"alternative-id":["20944","29113362"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20944","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,15]]}}}